γ-Glutamylcysteine ameliorates oxidative injury in neurons and astrocytes in vitro and increases brain glutathione in vivo

NeuroToxicology

Volumn 32, Issue 5, 2011, Pages 518-525

  Le, Truc M ^a   Jiang, Haiyan ^b   Cunningham, Gary R ^b   Magarik, Jordan A ^b   Barge, William S ^b   Cato, Marilyn C ^b   Farina, Marcelo ^c   Rocha, Joao B T ^d   Milatovic, Dejan ^b   Lee, Eunsook ^b   Aschner, Michael ^b   Summar, Marshall L ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Astrocyte; Glutathione; Neuron; Reactive oxygen species; Glutamylcysteine

Indexed keywords

GAMMA GLUTAMYLCYSTEINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; ISOPROSTANE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BRAIN; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; HEART; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; LIVER; LUNG; MOUSE; MUSCLE TISSUE; NERVE CELL; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

MUS;

EID: 84984590266     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.11.008     Document Type: Article

References (40)

1. Anderson M.E., Meister A. Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis. Proc Natl Acad Sci USA 1983, 80(3):707-711.
2. Aschner M., Mullaney K.J., Wagoner D., Lash L.H., Kimelberg H.K. Intracellular glutathione (GSH) levels modulate mercuric chloride (MC)- and methylmercuric chloride (MeHgCl)-induced amino acid release from neonatal rat primary astrocytes cultures. Brain Res 1994, 664(1-2):133-140.
3. Banaclocha M.M. Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases. Med Hypotheses 2001, 56(4):472-477.
4. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease?. Neurobiol Aging 1995, 16(4):661-674.
5. Bradley J.L., Homayoun S., Hart P.E., Schapira A.H., Cooper J.M. Role of oxidative damage in Friedreich's ataxia. Neurochem Res 2004, 29(3):561-567.
6. Candelario-Jalil E., Al-Dalain S.M., Castillo R., Martínez G., Fernández O.S. Selective vulnerability to kainate-induced oxidative damage in different rat brain regions. J Appl Toxicol 2001, 21(5):403-407.
7. Chance R., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979, 59(3):527-605.
8. Cohen M.D., Wei C.I. Effects of ammonium metavanadate treatment upon macrophage glutathione redox cycle activity, superoxide production, and intracellular glutathione status. J Leukoc Biol 1988, 44(2):122-129.
9. Eimerl S., Schramm M. An endogenous metal appears to regulate NMDA receptor mediated 45Ca influx and toxicity in cultured cerebellar granule cells. Neurosci Lett 1992, 137(2):198-202.
10. Fariss M.W., Reed D.J. High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Methods Enzymol 1987, 143:101-109.
11. Grant C.M., MacIver F.H., Dawes I.W. Glutathione synthetase is dispensable for growth under both normal and oxidative stress conditions in the yeast Saccharomyces cerevisiae due to an accumulation of the dipeptide gamma-glutamylcysteine [In Process Citation]. Mol Biol Cell 1997, 8(9):1699-1707.
12. Halliwell B., Gutteridge J.M. The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med 1985, 8(2):89-193.
13. Higgins D., Banker G. Primary dissociated cell cultures. Culturing Nerve Cells 1998, 37-78. MIT Press, Cambridge MA. G. Banker, K. Goslin (Eds.).
14. Janáky R., Varga V., Saransaari P., Oja S.S. Glutathione modulates the N-methyl-d-aspartate receptor-activated calcium influx into cultured rat cerebellar granule cells. Neurosci Lett 1993, 156(1-2):153-157.
15. Jewell S.A., Bellomo G., Thor H., Orrenius S., Smith M. Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. Science 1982, 217(4566):1257-1259.
16. Joshi G., Hardas S., Sultana R., St Clair D.K., Vore M., Butterfield D.A. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain. J Neurosci Res 2007, 85(3):497-503.
17. Kranich O., Dringen R., Sandberg M., Hamprecht B. Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine. Glia 1998, 22(1):11-18.
18. Lash L.H., Tokarz J.J. Oxidative stress in isolated rat renal proximal and distal tubular cells. Am J Physiol 1990, 259(2 Pt 2):F338-F347.
19. Lash L.H., Woods E.B. Cytotoxicity of alkylating agents in isolated rat kidney proximal tubular and distal tubular cells. Arch Biochem Biophys 1991, 286(1):46-56.
20. Lauterburg B.H., Corcoran G.B., Mitchell J.R. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983, 71(4):980-991.
21. Le T.M., Willis A.S., Barr F.E., Cunningham G.R., Canter J.A., Owens S.E., et al. An ethnic-specific polymorphism in the catalytic subunit of glutamate-cysteine ligase impairs the production of glutathione intermediates in vitro. Mol Genet Metab 2010, 101(1):55-61.
22. LeBel C.P., Bondy S.C. Oxygen radicals: common mediators of neurotoxicity. Neurotoxicol Teratol 1991, 13(3):341-346.
23. Lehmann A., Hagberg H., Orwar O., Sandberg M. Cysteine sulphinate and cysteate: mediators of cysteine toxicity in the neonatal rat brain?. Eur J Neurosci 1993, 5(10):1398-1412.
24. Lovell M.A., Xie C., Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 1998, 51(6):1562-1566.
25. Mead J. Free radical mechanisms of lipid damage and consequences for cellular membranes. Free Radicals in Biology 1976, vol. 1:51-68. Academic Press., New York.
26. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem 1983, 52:711-760.
27. Morrow, J. D. and L. J. Roberts, 2nd (1999). Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 300: 3-12.
28. Nancy V., Wolthuis R.M., de Tand M.F., Janoueix-Lerosey I., Bos J.L., de Gunzburg J. Identification and characterization of potential effector molecules of the Ras-related GTPase Rap2. J Biol Chem 1999, 274(13):8737-8745.
29. Orrenius S., Ormstad K., Thor H., Jewell S.A. Turnover and functions of glutathione studied with isolated hepatic and renal cells. Fed Proc 1983, 42(15):3177-3188.
30. Paintlia M.K., Paintlia A.S., Barbosa E., Singh I., Singh A.K. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 2004, 78(3):347-361.
31. Pocernich C.B., La Fontaine M., Butterfield D.A. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem Int 2000, 36(3):185-191.
32. Puka-Sundvall M., Eriksson P., Nilsson M., Sandberg M., Lehmann A. Neurotoxicity of cysteine: interaction with glutamate. Brain Res 1995, 705(1-2):65-70.
33. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000, 267(16):4904-4911.
34. Shanker G., Allen J.W., Mutkus L.A., Aschner M. Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons. Brain Res 2001, 914(1-2):159-165.
35. Townsend D.M., Tew K.D., Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003, 57(3-4):145-155.
36. Traystman R.J., Kirsch J.R., Koehler R.C. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991, 71(4):1185-1195.
37. Wang J., Fields J., Zhao C., Langer J., Thimmulappa R.K., Kensler T.W., et al. Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic Biol Med 2007, 43(3):408-414.
38. Wang X.F., Cynader M.S. Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem 2000, 74(4):1434-1442.
39. White A.R., Collins S.J., Maher F., Jobling M.F., Stewart L.R., Thyer J.M., et al. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 1999, 155(5):1723-1730.
40. Youdim M.B. Iron in the brain: implications for Parkinson's and Alzheimer's diseases. Mt Sinai J Med 1988, 55(1):97-101.